Filing Flows › Amgen (AMGN) › Free cash flow
Amgen (AMGN) free cash flow by quarter
Amgen's free cash flow was $3.7B in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 7 quarters it ranged from $991M (Q1 2025) to $4.2B (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.7B | +4% | -14% |
| Q2 2026 | $3.5B | +135% | +83% |
| Q1 2026 | $1.5B | +48% | +50% |
| Q4 2025 | $1.0B | -76% | — |
| Q3 2025 | $4.2B | +122% | — |
| Q2 2025 | $1.9B | +93% | — |
| Q1 2025 | $991M | — | — |
Q3 2026 at a glance
Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Amgen's free cash flow?
Amgen's free cash flow was $3.7B in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has Amgen's free cash flow changed?
Over the last 7 quarters it ranged from $991M (Q1 2025) to $4.2B (Q3 2025).